What side effects are associated with this type of intervention?

Common treatments for musculoskeletal issues, such as manual therapy and exercise, which are often part of SAW/RTW Coordination Services, have known side effects. Manual therapy can lead to minor or moderate transient adverse events in approximately 22-41% of cases, such as soreness or discomfort, while major adverse events are rare (0.13%). Exercise interventions generally have a similar risk profile to manual therapy, with minor side effects like muscle soreness. These treatments are generally safer compared to drug therapies, which have a higher risk of adverse events.

What prior FDA approvals exist?

The FDA has approved various treatments aimed at managing disabilities and improving quality of life, which indirectly support continued employment and reduce reliance on disability programs. For instance, medications like corticosteroids (e.g., prednisone and deflazacort) are used in conditions like Duchenne Muscular Dystrophy to slow disease progression and maintain physical function. Additionally, disease-modifying treatments for conditions such as multiple sclerosis (e.g., interferons, glatiramer acetate) help manage symptoms and reduce relapses, thereby supporting patients' ability to remain in the workforce. These treatments, while not directly part of SAW/RTW Coordination Services, contribute to the broader goal of enabling individuals with disabilities to maintain employment.

What other types of research exist?

Promising, novel alternatives to SAW/RTW Coordination Services for disability patients in 2024 include: 1) eHealth home training applications, which provide remote, app-based self-training and teleconference peer-led training; 2) Telehealth services that offer virtual consultations and therapy sessions; 3) Interactive peer-led training programs using experienced and proficient users to guide new patients; 4) Advanced therapeutic technologies such as robotic assistance, virtual/augmented reality therapies, and body weight support systems to enhance rehabilitation outcomes.

← Back to Search

RETAINWORKS Program for Disability

N/A

Recruiting

Led By Jill Berk, PhD

Research Sponsored by Mathematica Policy Research, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured in the 12 months after enrollment.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests the RETAINWORKS program, which helps injured or ill workers stay in their jobs or return to work. It targets people at risk of leaving the workforce and needing public support. The program trains doctors, coordinates job and health services, and provides support from nurses and job experts, with financial rewards for progress.

Who is the study for?

The RETAINWORKS trial is for individuals aged 18-65 in Kansas who are employed or seeking employment and have a new or worsening health condition affecting their work. Conditions may include musculoskeletal injuries, mental health issues, chronic diseases like diabetes, COPD, CHF, among others. Participants must not be receiving or applying for SSDI/SSI benefits due to the injury or illness.

What is being tested?

RETAINWORKS aims to help people with disabilities stay in the workforce by providing medical services and coordination support. The study will assess how well these services work in Kansas by looking at participants' job retention and productivity after they receive assistance from the program.

What are the potential side effects?

Since RETAINWORKS is a service-based intervention rather than a medical treatment, there are no direct side effects like those associated with medications. However, participants may experience varying degrees of success with the program's ability to assist them in retaining employment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured over the three months in the fourth quarter after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured over the three months in the fourth quarter after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured over the three months in the fourth quarter after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Enrollee earnings in the fourth quarter after enrollment

Share of enrollees employed in the fourth quarter after enrollment

Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: RETAIN ProgrammingExperimental Treatment1 Intervention

The experimental group receives the full set of RETAINWORKS intervention activities.

Group II: ControlActive Control1 Intervention

The control group receives information and referral to partner services.

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for disability, particularly those similar to SAW/RTW Coordination Services, involve a combination of medical provider services, stay-at-work/return-to-work coordination, and other supportive services. These treatments aim to address both the medical and vocational needs of patients, ensuring they receive comprehensive care that enables them to remain in or return to the workforce. This approach is crucial for disability patients as it improves health outcomes, promotes independence, and reduces financial strain by facilitating continued employment.

Description of health-related rehabilitation service provision and delivery in randomized controlled trials: A topic review.Protocol for the ROBUST (Registry Of type B aortic dissection with the Utility of STent graft) study: an ambispective, multicentre, open cohort study.Effect of affordable technology on physical activity levels and mobility outcomes in rehabilitation: a protocol for the Activity and MObility UsiNg Technology (AMOUNT) rehabilitation trial.